These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30708381)

  • 1. Outcomes in Patients with Left Ventricular Assist Devices, Pacemakers, and Implantable Cardioverter Defibrillators Undergoing Single Balloon Enteroscopy.
    Patel B; Shiani A; Rodriguez AC; Lipka S; Davis-Yadley AH; Nelson KK; Rabbanifard R; Kumar A; Brady PG
    South Med J; 2019 Feb; 112(2):130-134. PubMed ID: 30708381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices.
    Enriquez AD; Calenda B; Miller MA; Anyanwu AC; Pinney SP
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):668-74. PubMed ID: 23873139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable Cardioverter-Defibrillator Use in Patients With Left Ventricular Assist Devices: A Systematic Review and Meta-Analysis.
    Vakil K; Kazmirczak F; Sathnur N; Adabag S; Cantillon DJ; Kiehl EL; Koene R; Cogswell R; Anand I; Roukoz H
    JACC Heart Fail; 2016 Oct; 4(10):772-779. PubMed ID: 27395347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Randomized Evaluation of Implantable Cardioverter-Defibrillator Programming in Patients With a Left Ventricular Assist Device.
    Richardson TD; Hale L; Arteaga C; Xu M; Keebler M; Schlendorf K; Danter M; Shah A; Lindenfeld J; Ellis CR
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29475875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of cardiac resynchronization therapy on clinical outcomes in patients with continuous-flow left ventricular assist devices.
    Gopinathannair R; Birks EJ; Trivedi JR; McCants KC; Sutton BS; Deam AG; Slaughter MS; Hottigoudar RU
    J Card Fail; 2015 Mar; 21(3):226-32. PubMed ID: 25528199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Implantable Cardioverter Defibrillators on Survival of Patients with Centrifugal Left Ventricular Assist Devices.
    Lee W; Tay A; Subbiah RN; Walker BD; Kuchar DL; Muthiah K; Macdonald PS; Keogh AM; Kotlyar E; Jabbour A; Spratt P; Jansz PC; Granger E; Dhital K; Hayward CS
    Pacing Clin Electrophysiol; 2015 Aug; 38(8):925-33. PubMed ID: 25940215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival Benefit of Implantable-Cardioverter Defibrillator Therapy in Ambulatory Patients With Left Ventricular Assist Device.
    Simsek E; Nalbantgil S; Demir E; Kemal HS; Mutlu I; Ozturk P; Engin C; Yagdi T; Ozbaran M
    Transplant Proc; 2019 Dec; 51(10):3403-3408. PubMed ID: 31732208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable cardioverter defibrillators in left ventricular assist device patients: Α systematic review and meta-analysis.
    Rorris FP; Antonopoulos CN; Kyriakopoulos CP; Drakos SG; Charitos C
    J Heart Lung Transplant; 2021 Oct; 40(10):1098-1106. PubMed ID: 34176727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous use of implantable cardioverter-defibrillators and left ventricular assist devices in patients with severe heart failure.
    Kühne M; Sakumura M; Reich SS; Sarrazin JF; Wells D; Chalfoun N; Crawford T; Boonyapisit W; Horwood L; Chugh A; Good E; Jongnarangsin K; Bogun F; Oral H; Morady F; Pagani F; Pelosi F
    Am J Cardiol; 2010 Feb; 105(3):378-82. PubMed ID: 20102952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices - A meta-analysis.
    Agrawal S; Garg L; Nanda S; Sharma A; Bhatia N; Manda Y; Singh A; Fegley M; Shirani J
    Int J Cardiol; 2016 Nov; 222():379-384. PubMed ID: 27505320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable Cardioverter Defibrillators and Survival in Continuous-Flow Left Ventricular Assist Device Patients.
    Kutyifa V; Fernandez G; Sherazi S; Aktas M; Huang D; McNitt S; Papernov A; Wang M; Massey HT; Chen L; Alexis JD
    ASAIO J; 2019 Jan; 65(1):49-53. PubMed ID: 29215366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable Cardioverter Defibrillators in Patients With Continuous Flow Left Ventricular Assist Devices: Utilization Patterns, Related Procedures, and Complications.
    Alvarez PA; Sperry BW; Pérez AL; Yaranov DM; Randhawa V; Luthman J; Cantillon DJ; Starling RC
    J Am Heart Assoc; 2019 Jul; 8(14):e011813. PubMed ID: 31280637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) Technical Review.
    Rondonotti E; Spada C; Adler S; May A; Despott EJ; Koulaouzidis A; Panter S; Domagk D; Fernandez-Urien I; Rahmi G; Riccioni ME; van Hooft JE; Hassan C; Pennazio M
    Endoscopy; 2018 Apr; 50(4):423-446. PubMed ID: 29539652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wearable cardioverter defibrillator: bridging for implantable defibrillators in left ventricular assist device patients.
    Rorris FP; Charitos C
    Heart Fail Rev; 2021 Jul; 26(4):763-765. PubMed ID: 33404997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation.
    Raasch H; Jensen BC; Chang PP; Mounsey JP; Gehi AK; Chung EH; Sheridan BC; Bowen A; Katz JN
    Am Heart J; 2012 Sep; 164(3):373-8. PubMed ID: 22980304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ICD lead parameters, performance, and adverse events following continuous-flow LVAD implantation.
    Thomas IC; Cork DP; Levy A; Nayak H; Beshai JF; Burke MC; Moss JD
    Pacing Clin Electrophysiol; 2014 Apr; 37(4):464-72. PubMed ID: 24237034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
    Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of a fully magnetically levitated left ventricular assist device on functional interrogation of implantable cardioverter defibrillators.
    Schukro C; Schlöglhofer T; Khazen C; Röhrich M; Laufer G; Zimpfer D; Wiedemann D
    Clin Cardiol; 2019 Oct; 42(10):914-918. PubMed ID: 31282021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes and Predictors of Readmissions with GI Bleeding in Patients with Left Ventricular Assist Devices.
    Shah R; Qayed E
    South Med J; 2018 Nov; 111(11):666-673. PubMed ID: 30392001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome and Safety of Anterograde and Retrograde Single-Balloon Enteroscopy: Clinical Experience at a Tertiary Medical Center in Taiwan.
    Lin MC; Chen PJ; Shih YL; Huang HH; Chang WK; Hsieh TY; Huang TY
    PLoS One; 2016; 11(8):e0161188. PubMed ID: 27548619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.